Savara (SVRA) Interest & Investment Income (2010 - 2026)
Savara's (SVRA) quarterly Interest & Investment Income came in at -$247000.0 in Q1 2026, down 60.39% year-on-year from -$623573.8 in Q1 2025, and down 314.78% on a QoQ basis from $115000.0 in Q4 2025.
Savara (SVRA) Interest & Investment Income (2010 - 2026) Analysis & Trends
Savara (SVRA) has 17 years of Interest & Investment Income data on file, last reported at -$247000.0 in Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 60.39% year-over-year to -$247000.0 in Q1 2026; TTM through Mar 2026 was -$95000.0, a 167.38% decrease from a year earlier, with the FY2025 full-year figure at -$2000.0, down 104.55% from the prior year.
- Interest & Investment Income for Q1 2026 stood at -$247000.0, down from $115000.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for SVRA reached as high as $583000.0 in Q3 2024 and fell as low as -$263000.0 in Q4 2024.
- Historically, Interest & Investment Income has averaged $2000.0 across 5 years, with a median of -$5000.0 in 2023.
- On a YoY basis, Interest & Investment Income climbed as much as 11760.0% in 2024 and fell as far as 1892.86% in 2024.
- Year by year, Interest & Investment Income stood at $29000.0 in 2022, then soared by 768.97% to $252000.0 in 2023, then tumbled by 204.37% to -$263000.0 in 2024, then surged by 143.73% to $115000.0 in 2025, then plunged by 314.78% to -$247000.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were -$247000.0 in Q1 2026, $115000.0 in Q4 2025, and $123000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Savara | 1.39 Bn | 1.39 Bn | - | -247,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -247,000.00 |
| Dec 31, 2025 | 115,000.00 |
| Sep 30, 2025 | 123,000.00 |
| Jun 30, 2025 | -86,000.00 |
| Mar 31, 2025 | -154,000.00 |
| Dec 31, 2024 | -263,000.00 |
| Sep 30, 2024 | 583,000.00 |
| Jun 30, 2024 | -25,000.00 |
| Mar 31, 2024 | -251,000.00 |
| Dec 31, 2023 | 252,000.00 |
| Sep 30, 2023 | -5,000.00 |
| Jun 30, 2023 | -60,000.00 |
| Mar 31, 2023 | 14,000.00 |
| Dec 31, 2022 | 29,000.00 |
| Sep 30, 2022 | 77,000.00 |
| Jun 30, 2022 | 20,000.00 |
| Mar 31, 2022 | -88,000.00 |
| Dec 31, 2021 | -38,000.00 |
| Sep 30, 2021 | -10,000.00 |
| Jun 30, 2021 | 24,000.00 |